Clinical trial Recruiting at 1 site Observational Ages 18 to 65

Endoscopic gastric tubulization for weight loss

Official title: Endoscopic Gastric Tubulization

Run by IHU Strasbourg · NCT03554902 · Data updated 2026-11-12

This study is testing a new, less invasive procedure to help adults with severe obesity lose weight and improve their quality of life by making their stomach smaller without surgery.

Quick facts

Study typeObservational
Ages18 Years to 65 Years
SexAll
Enrollment300 (estimated)
SponsorIHU Strasbourg
Academic / other
Locations1 site (Strasbourg)
StatusRecruiting
StartedJune 8, 2018
Main results expectedJune 2028
Study endsJune 2028
Registry record updatedMay 1, 2025
Trial IDNCT03554902 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adult patients scheduled for endoscopic gastric tubulization at the Nouvel Hôpital Civil.

Probably not a fit

Patients who are not candidates for endoscopic procedures or those with contraindications to gastric tubulization may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study evaluates the outcomes of endoscopic gastric tubulization in adult patients with morbid obesity at the Nouvel Hôpital Civil in Strasbourg, France. The procedure utilizes a specialized endoscopic suture device to reduce stomach size without incisions, aiming to achieve weight loss and improve quality of life. Data will be collected from patients before the procedure and up to two years post-procedure to assess weight loss, quality of life, and improvement in obesity-related comorbidities. The approach is designed to be less invasive than traditional bariatric surgery, with a focus on safety and reversibility.

Why it matters

Potential benefit: If successful, this procedure could provide a safer, less invasive option for significant weight loss and improved quality of life for patients with morbid obesity.

How similar studies have gone: Other studies have shown promising results with similar endoscopic approaches for weight loss, indicating potential for success in this novel application.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients scheduled for an endoscopic gastric tubulization in the Nouvel Hôpital Civil, Strasbourg, France

Where it's running

  • Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil
    Strasbourg, France
    Recruiting

Study contacts

  • Principal investigator: Silvana Perretta, MD, PhD — Service de Chirurgie Digestive et Endocrinienne - Nouvel Hôpital Civil - Strasbourg
  • Study coordinator: Silvana Perretta, MD, PhD
  • Email: silvana.perretta@ircad.fr
  • Phone: + 33 3 69 55 05 31

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.